Subcutaneous Immunoglobulin for Myasthenia Gravis
Clinical trial NCT04728425 · COMPLETED
Trial details
- NCT number
- NCT04728425
- Sponsor
- University Health Network, Toronto
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-28
- Primary completion
- 2023-06-30
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.